P

Pear Therapeutics Inc
NASDAQ:PEAR

Watchlist Manager
Pear Therapeutics Inc
NASDAQ:PEAR
Watchlist
Price: 0.0077 USD -15.38% Market Closed
Updated: May 19, 2024

Pear Therapeutics Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pear Therapeutics Inc
Operating Expenses Peer Comparison

Comparables:
VEEV
INSP
EVH
DOCS
GDRX

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
P
Pear Therapeutics Inc
NASDAQ:PEAR
Operating Expenses
-$122.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Veeva Systems Inc
NYSE:VEEV
Operating Expenses
-$1.3B
CAGR 3-Years
-23%
CAGR 5-Years
-26%
CAGR 10-Years
-30%
Inspire Medical Systems Inc
NYSE:INSP
Operating Expenses
-$595.4m
CAGR 3-Years
-52%
CAGR 5-Years
-53%
CAGR 10-Years
N/A
Evolent Health Inc
NYSE:EVH
Operating Expenses
-$425.7m
CAGR 3-Years
-14%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Operating Expenses
-$252.9m
CAGR 3-Years
-27%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
Goodrx Holdings Inc
NASDAQ:GDRX
Operating Expenses
-$708.6m
CAGR 3-Years
4%
CAGR 5-Years
-34%
CAGR 10-Years
N/A

See Also

What is Pear Therapeutics Inc's Operating Expenses?
Operating Expenses
-122.5m USD

Based on the financial report for Dec 31, 2022, Pear Therapeutics Inc's Operating Expenses amounts to -122.5m USD.

What is Pear Therapeutics Inc's Operating Expenses growth rate?
Operating Expenses CAGR 1Y
-17%

Over the last year, the Operating Expenses growth was -17%.